FDA Drug Application (021977) for VYVANSE by SHIRE DEVELOPMENT

Back to FDA Applications sponsored by SHIRE DEVELOPMENT

Application Number021977
Product Number001
FormCAPSULE;ORAL
Dosage30MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameVYVANSE
Active IngredientLISDEXAMFETAMINE DIMESYLATE

Active IngredientCount
List of drugs with Active Ingredient LISDEXAMFETAMINE DIMESYLATE2


Back to FDA Applications sponsored by SHIRE DEVELOPMENT